HK1021733A1 - Thiazole derivatives - Google Patents
Thiazole derivativesInfo
- Publication number
- HK1021733A1 HK1021733A1 HK00100585A HK00100585A HK1021733A1 HK 1021733 A1 HK1021733 A1 HK 1021733A1 HK 00100585 A HK00100585 A HK 00100585A HK 00100585 A HK00100585 A HK 00100585A HK 1021733 A1 HK1021733 A1 HK 1021733A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- thiazole derivatives
- thiazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Virology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98100007 | 1998-01-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1021733A1 true HK1021733A1 (en) | 2000-06-30 |
Family
ID=8231230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK00100585A HK1021733A1 (en) | 1998-01-02 | 2000-01-31 | Thiazole derivatives |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6001855A (xx) |
| JP (1) | JP3154982B2 (xx) |
| KR (1) | KR100312900B1 (xx) |
| CN (1) | CN1098849C (xx) |
| AR (1) | AR014211A1 (xx) |
| AT (1) | ATE217621T1 (xx) |
| AU (1) | AU718659B2 (xx) |
| BR (1) | BR9805750A (xx) |
| CA (1) | CA2257322C (xx) |
| CO (1) | CO4990935A1 (xx) |
| DE (1) | DE69805392T2 (xx) |
| DK (1) | DK0928793T3 (xx) |
| ES (1) | ES2176895T3 (xx) |
| HK (1) | HK1021733A1 (xx) |
| HR (1) | HRP980644B1 (xx) |
| HU (1) | HUP9803041A3 (xx) |
| ID (1) | ID21878A (xx) |
| IL (1) | IL127784A (xx) |
| MA (1) | MA26590A1 (xx) |
| NO (1) | NO312134B1 (xx) |
| PE (1) | PE20000116A1 (xx) |
| PL (1) | PL330620A1 (xx) |
| PT (1) | PT928793E (xx) |
| RU (1) | RU2166503C2 (xx) |
| SG (1) | SG72911A1 (xx) |
| TR (1) | TR199802766A2 (xx) |
| UY (1) | UY25335A1 (xx) |
| YU (1) | YU60998A (xx) |
| ZA (1) | ZA9811923B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4517454B2 (ja) * | 2000-06-01 | 2010-08-04 | 宇部興産株式会社 | ４−（１−フルオロエチル）チアゾール−５−カルボン酸アミド誘導体及び農園芸用の有害生物防除剤 |
| US6420566B2 (en) * | 2000-06-09 | 2002-07-16 | Aventis Pharma S.A. | Pharmaceutical compositions containing a 4, 5-dihydro-1, 3-thiazol-2-ylamine derivative, novel derivatives and preparation thereof |
| US6451821B1 (en) * | 2000-06-09 | 2002-09-17 | Aventis Pharma S.A. | Use of 2-aminothiazoline derivatives as inhibitors of inducible no-synthase |
| SG11201803781XA (en) * | 2015-12-04 | 2018-06-28 | Janssen Biotech Inc | Treatment of retinal degeneration using progenitor cells |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2138803B (en) * | 1983-04-26 | 1986-06-18 | Shionogi & Co | 2-guanidino-4-hydroxymethylthiazole and derivatives thereof |
| IL95548A0 (en) * | 1989-09-15 | 1991-06-30 | Fujisawa Pharmaceutical Co | Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same |
| TW201303B (xx) * | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
| RO118289B1 (ro) * | 1995-08-30 | 2003-04-30 | Gd Searle & Co Chicago | Derivati de fenilcarboniluree si compozitie farmaceutica |
| WO1997026250A1 (en) * | 1996-01-16 | 1997-07-24 | Merck & Co., Inc. | Integrin receptor antagonists |
| ATE334975T1 (de) * | 1997-05-30 | 2006-08-15 | Takeda Pharmaceutical | Sulfonamidderivate, ihre herstellung und verwendung |
-
1998
- 1998-12-22 US US09/218,200 patent/US6001855A/en not_active Expired - Fee Related
- 1998-12-28 NO NO19986160A patent/NO312134B1/no unknown
- 1998-12-29 HR HR980644A patent/HRP980644B1/xx not_active IP Right Cessation
- 1998-12-29 IL IL12778498A patent/IL127784A/en not_active IP Right Cessation
- 1998-12-29 ZA ZA9811923A patent/ZA9811923B/xx unknown
- 1998-12-29 YU YU60998A patent/YU60998A/sh unknown
- 1998-12-29 PE PE1998001292A patent/PE20000116A1/es not_active Application Discontinuation
- 1998-12-29 AR ARP980106722A patent/AR014211A1/es not_active Application Discontinuation
- 1998-12-30 PL PL98330620A patent/PL330620A1/xx not_active Application Discontinuation
- 1998-12-30 ES ES98124819T patent/ES2176895T3/es not_active Expired - Lifetime
- 1998-12-30 CO CO98077474A patent/CO4990935A1/es unknown
- 1998-12-30 SG SG1998005979A patent/SG72911A1/en unknown
- 1998-12-30 TR TR1998/02766A patent/TR199802766A2/xx unknown
- 1998-12-30 HU HU9803041A patent/HUP9803041A3/hu unknown
- 1998-12-30 AT AT98124819T patent/ATE217621T1/de not_active IP Right Cessation
- 1998-12-30 AU AU96145/98A patent/AU718659B2/en not_active Ceased
- 1998-12-30 MA MA25410A patent/MA26590A1/fr unknown
- 1998-12-30 CA CA002257322A patent/CA2257322C/en not_active Expired - Fee Related
- 1998-12-30 KR KR1019980061644A patent/KR100312900B1/ko not_active IP Right Cessation
- 1998-12-30 DE DE69805392T patent/DE69805392T2/de not_active Expired - Fee Related
- 1998-12-30 PT PT98124819T patent/PT928793E/pt unknown
- 1998-12-30 DK DK98124819T patent/DK0928793T3/da active
- 1998-12-31 UY UY25335A patent/UY25335A1/es not_active IP Right Cessation
- 1998-12-31 BR BR9805750-2A patent/BR9805750A/pt not_active Application Discontinuation
- 1998-12-31 CN CN98125981A patent/CN1098849C/zh not_active Expired - Fee Related
-
1999
- 1999-01-04 JP JP00020699A patent/JP3154982B2/ja not_active Expired - Fee Related
- 1999-01-04 ID IDP990002A patent/ID21878A/id unknown
- 1999-01-05 RU RU99100205/04A patent/RU2166503C2/ru not_active IP Right Cessation
-
2000
- 2000-01-31 HK HK00100585A patent/HK1021733A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI0928790T1 (en) | Thiazole derivatives | |
| EG24464A (en) | Epothilone derivatives | |
| PL346155A1 (en) | 1h-imidazopyridine derivatives | |
| PL345540A1 (en) | Thiobenzimidazole derivatives | |
| HK1022310A1 (en) | Benzosulfone derivatives | |
| EP1120407A4 (en) | CYSTEINE DERIVATIVES | |
| GB9809664D0 (en) | a-Ketoamide derivatives | |
| IL127785A0 (en) | Thiazole derivatives | |
| GB9821302D0 (en) | Insecticidal thiazole derivatives | |
| EG23802A (en) | 2-Phenylpyran-4-one derivatives | |
| SI0928793T1 (en) | Thiazole derivatives | |
| IL142090A0 (en) | Thiazole derivatives | |
| GB9827729D0 (en) | Thieno-indole derivatives | |
| HRP980644B1 (en) | Thiazole derivatives | |
| EP1061912A4 (en) | PHENANTHROFURANDERIVATE | |
| IL139276A0 (en) | Cyclohexenondioxthio chromanoyl derivatives | |
| HK1040702A1 (zh) | 亞氨酰胺衍生物 | |
| HK1042478A1 (zh) | 2-氧代-2h-喹啉衍生物 | |
| GB9807118D0 (en) | Thiazole derivatives | |
| LT99153A (en) | Epothilone derivatives | |
| AUPP359198A0 (en) | Thiazole derivatives | |
| GB9600199D0 (en) | Thiazole derivatives | |
| GB9816279D0 (en) | Arylthiazolidinedione derivatives | |
| SI1051395T1 (sl) | N-hidroksiformamidni derivati | |
| GB9812410D0 (en) | Heterocyclic derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20061231 |